Since its establishment, the company insists on operation principle of “regarding honesty as basis and establishing by credit” all the time, relies on capital operation to increase strength and reform management to improve vitality. It realizes a successful transformation from trade type company into comprehensive type group company, and is developed into large enterprise that is engaged in coal chemical industry and medical industry as well as various fields including international trade and real estate. The company has 6 sole capital subsidiary companies such as China Shandong Group (Hong Kong), Shandong Hualu Group, Shandong Hualu Hengsheng Group, Shandong Xinhua Pharmaceutical Group and Shandong Lukang Pharmaceutical Group, 3 listed companies, 4 stocks, 16,000 employees and total asset of over 20 billion Yuan. The company owns the largest DMF (dimethyl formamide) producer in the world, the largest febrifuge and pain easing type medicine production base in Asia and important nitrogenous fertilizer, heart and cerebrovascular medicine, antibiotic and biologic pharmaceutical production base in China.
Coal chemical industry
Coal chemical industry involves four series of fertilizer, chemical industry, thermal electricity and gas. The group has an annual production capacity with carbamide of 1.5 million tons, phenylglycinol of 1.2 million tons, DMF of 250,000 tons, carbinamine of 200,000 tons, acetic acid of 400,000 tons, acetic anhydride of 28,000 tons, power generation of 200,000 KW, heating supply of 20 million GJ and industrial gas of 100,000 tons, and it is the largest DMF supplier in the world and one of large fertilizer enterprises in China. Its main product – carbamide takes in the rank of first 5 positions in domestic markets.
Pharmaceutical industry is mainly engaged in research, development, production and sales of various products such as Pharmaceutical Intermediates, Active Pharmaceutical Ingredients (API) by-chemical synthesis and, biologic fermentation (antibiotic), Finished Dosage Forms, Veterinary drugs and Pesticides. The group has annual production capacity of APIs of 33,000 tons,14.5 billion tablets, 1.8 billion injections, 2.3 billion capsules and infusion of 100 million bottles. Its production scale of APIs such as analgin, caffeine, aspirin, ibuprofen and L-380 (levodopa) takes the first position in the world, output of various products such as nimodipine, spectinomycin and mezlocillin takes the first potion in the whole country, and its products are sold to over 100 countries and areas.